Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy

Lake, Jordan E;for the ACTG A5322 Study Team;Wu, Kunling;for the ACTG A5322 Study Team;Bares, Sara H;for the ACTG A5322 Study Team;Debroy, Paula;for the ACTG A5322 Study Team;Godfrey, Catherine;for the ACTG A5322 Study Team;Koethe, John R;for the ACTG A5322 Study Team;McComsey, Grace A;for the ACTG A5322 Study Team;Palella, Frank J;for the ACTG A5322 Study Team;Tassiopoulos, Katherine;for the ACTG A5322 Study Team;Erlandson, Kristine M;for the ACTG A5322 Study Team;
clinical infectious diseases pp. -
214
eclinicalrisk

Abstract

We report the first data on within-person weight trajectories following switch to integrase inhibitor-based antiretroviral therapy while virologically suppresse

Keywords

Citation

ID: 110955
Ref Key: eclinicalrisk
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
110955
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
4/5
Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Saymatik Web3.0 Wallet